company background image
IPD logo

ImpediMed ASX:IPD Stock Report

Last Price

AU$0.083

Market Cap

AU$170.0m

7D

2.5%

1Y

43.1%

Updated

20 Feb, 2024

Data

Company Financials +

IPD Stock Overview

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally.

IPD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ImpediMed Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ImpediMed
Historical stock prices
Current Share PriceAU$0.083
52 Week HighAU$0.24
52 Week LowAU$0.056
Beta2.97
1 Month Change-38.52%
3 Month Change-33.60%
1 Year Change43.10%
3 Year Change-36.15%
5 Year Change-66.12%
Change since IPO-90.24%

Recent News & Updates

Recent updates

Companies Like ImpediMed (ASX:IPD) Are In A Position To Invest In Growth

Nov 23
Companies Like ImpediMed (ASX:IPD) Are In A Position To Invest In Growth

Is ImpediMed (ASX:IPD) In A Good Position To Deliver On Growth Plans?

Jul 11
Is ImpediMed (ASX:IPD) In A Good Position To Deliver On Growth Plans?

We Think ImpediMed (ASX:IPD) Needs To Drive Business Growth Carefully

Mar 27
We Think ImpediMed (ASX:IPD) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation

Sep 28
Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation

We're Not Worried About ImpediMed's (ASX:IPD) Cash Burn

Jun 10
We're Not Worried About ImpediMed's (ASX:IPD) Cash Burn

A Look At The Fair Value Of ImpediMed Limited (ASX:IPD)

Feb 01
A Look At The Fair Value Of ImpediMed Limited (ASX:IPD)

We Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growth

Aug 25
We Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation

Apr 06
Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation

Analysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before Long

Feb 12
Analysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before Long

ImpediMed's (ASX:IPD) Stock Price Has Reduced 88% In The Past Five Years

Jan 08
ImpediMed's (ASX:IPD) Stock Price Has Reduced 88% In The Past Five Years

How Does ImpediMed's (ASX:IPD) CEO Salary Compare to Peers?

Nov 25
How Does ImpediMed's (ASX:IPD) CEO Salary Compare to Peers?

Shareholder Returns

IPDAU Medical EquipmentAU Market
7D2.5%1.3%0.8%
1Y43.1%24.9%4.3%

Return vs Industry: IPD exceeded the Australian Medical Equipment industry which returned 24.3% over the past year.

Return vs Market: IPD exceeded the Australian Market which returned 4.4% over the past year.

Price Volatility

Is IPD's price volatile compared to industry and market?
IPD volatility
IPD Average Weekly Movement11.7%
Medical Equipment Industry Average Movement9.3%
Market Average Movement8.5%
10% most volatile stocks in AU Market16.7%
10% least volatile stocks in AU Market3.2%

Stable Share Price: IPD's share price has been volatile over the past 3 months.

Volatility Over Time: IPD's weekly volatility has decreased from 20% to 12% over the past year.

About the Company

FoundedEmployeesCEOWebsite
199976Parmjot Bainshttps://www.impedimed.com

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics.

ImpediMed Limited Fundamentals Summary

How do ImpediMed's earnings and revenue compare to its market cap?
IPD fundamental statistics
Market capAU$169.96m
Earnings (TTM)-AU$20.52m
Revenue (TTM)AU$11.34m

14.8x

P/S Ratio

-8.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IPD income statement (TTM)
RevenueAU$11.34m
Cost of RevenueAU$1.55m
Gross ProfitAU$9.80m
Other ExpensesAU$30.32m
Earnings-AU$20.52m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Feb 27, 2024

Earnings per share (EPS)-0.01
Gross Margin86.37%
Net Profit Margin-180.90%
Debt/Equity Ratio0%

How did IPD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.